World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02475811
Date of registration: 15/06/2015
Prospective Registration: No
Primary sponsor: Cairo University
Public title: 3D Ultrasonography Fetal Lung Volume Measurement and Neonatal Respiratory Function
Scientific title: The Role of 3D Ultrasonography Fetal Lung Volume Measurement in the Prediction of Neonatal Respiratory Function Outcome
Date of first enrolment: June 2015
Target sample size: 100
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02475811
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
Egypt
Contacts
Name:     Ahmed Maged
Address: 
Telephone:
Email:
Affiliation:  Kasr Alainy medical school
Key inclusion & exclusion criteria

Inclusion Criteria:

- One hundred healthy women with singleton pregnancies presented in the 1st stage of
labour were included in the study. Participants were divided into two groups; Group A
(n: 50 - women pregnant ± 34-37 weeks gestation) & Group B (n: 50 - women pregnant ±
37+1-40 weeks gestation). Gestational age (GA) is established by menstrual dates then
confirmed by obstetric ultrasound

Exclusion Criteria:

- Exclusion criteria include the maternal administration of respiratory depressants
within 2 hours from the delivery of the fetus (e. g., opioid analgesic & general
anesthesia upon doing CS) or oligohydramnios (amniotic fluid index < 5th centile),
rupture of membranes, the presence of fetal malformations (chest, heart or abdominal)
or abnormal fetal growth (defined as: estimated fetal weight < 5th centile or > 95th
centile and/or abdominal circumference < 5th centile or > 95th centile). Also, women
with a cardiac pacemaker were excluded (as the transmitter necessary for the lung
volume measurements could disturb the function of the pacemaker).



Age minimum: 18 Years
Age maximum: 40 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Neonatal Respiratory Function
Intervention(s)
Radiation: 3D ultrasonography
Primary Outcome(s)
Apgar score [Time Frame: 1 minute after delivery]
Secondary Outcome(s)
Apgar score [Time Frame: 5 minutes after delivery]
Neonatal ICU admission [Time Frame: 24 hour after delivery]
Secondary ID(s)
137
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history